Effects of Bifidobacterium triple viable entericcoated capsules on gastrointestinal hormones
Zhang Cheng1,Gao Zeli2
2019, 34(7):
629-632.
doi:10.3969/j.issn.1004-583X.2019.07.012
Asbtract
(
586 )
PDF (371KB)
(
119
)
HTML
Related Articles |
Metrics
Objective To study the effects of Bifidobacterium triple viable entericcoated capsules on symptoms score, gastrointestinal hormones and oxidative stress index in irritable bowel syndromeconstipation(IBSC) patients. Methods A total of 94 patients with IBSC treated in our hospital from January 2018 to December 2018 were selected, and they were randomly divided into control group(n=47) and observation group(n=47). The two groups of patients were treated with mosapride in combination with lactulose, with observation group added with Bifidobacterium triple live enteric capsules, and control group added with placebo. The clinical efficacy, clinical symptoms, gastrointestinal hormones, 5HT and oxidative stress were compared between two groups.Results In observation group, the treatment was markedly effective in 29 cases (61.70%), and effective in 15 cases (31.91%), with the total effective rate being 93.62%, and that of control group being 78.72%(P<0.05). After treatment, the scores of clinical symptoms in two groups decreased significantly. The scores of abdominal distension, abdominal pain, defecation frequency, stool characteristics and defecation difficulty in observation group were significantly lower than those in control group (P<0.05). After treatment, the levels of 5HT, MDA and LPO in two groups also witnessed significance decrease. The levels of 5HT, MDA and LPO in observation group were lower than those in control group (P<0.05). After treatment, the levels of gastrointestinal hormones in both groups were improved. The MTL level in observation group was higher than that in control group, and the levels of VIP and S S were lower than those in control group (P<0.05). Conclusion Bifidobacterium triple viable capsule combined with lactulose and Mosapride is effective in treatment of IBSC. It can significantly improve clinical symptoms and gastrointestinal hormone levels, reduce plasma 5HT level and oxidative stress response, which makes it is worthy of clinical application.